VIVUS Announces Multiple Presentations Featuring Long-term QNEXA Data at the American Diabetes Association 71st Scientific Sessions

VIVUS, Inc. VVUS today announced that multiple abstracts have been accepted for presentation at the upcoming American Diabetes Association meeting to be held June 24th to June 28th, 2011, at the San Diego Convention Center, San Diego, CA. Timothy Garvey, MD, Professor of Medicine and Chair of the Department of Nutrition Sciences at UAB, will present his findings on the impact of QNEXA treatment on metabolic syndrome. Donna Ryan, MD, Associate Executive Director for Clinical Research at Pennington Biomedical Research Center, will present her findings on the prevention of diabetes and normalization of fasting glucose in prediabetics after two years of QNEXA treatment. Lastly, Robert Kushner, MD, Clinical Director at Northwestern University Comprehensive Center on Obesity, will share his analysis of long-term weight loss with QNEXA and the resulting improvement in glycemic biomarkers. Top-line results from the SEQUEL study have been previously presented but the ADA presentations represent the first detailed presentation of glycemic data to ADA members. Details on the presentation times are as follows: